Medtronic Panel: Vision to Validation, am Business Cases in Med Device & Life Sciences

In the evolving landscape of medical devices, life sciences, and bioprinting, additive manufacturing (AM) presents transformative opportunities, but its adoption hinges on building a compelling business case.

Featuring panelists from Medtronic, B9Creations, and Project Synergy who have worked with CU Anshutz & Thermo Fisher, this session aims to equip leaders and innovators with actionable strategies for integrating AM technologies in ways that align with their organizational goals, helping them transform visionary ideas into validated, impactful solutions in medical device manufacturing and life sciences.

This live, in-depth discussion will delve into the key elements of an effective AM business case, from assessing initial feasibility to full-scale production, covering best practices for navigating strategic, technical, financial, and regulatory hurdles.

Attendees will gain a clearer understanding of how to:

• Evaluate AM’s value proposition within their organizations
• Identify measurable objectives and best use cases
• Build stakeholder support
• Present a well-rounded, validated case for AM adoption
• Help participants bridge the gap from innovation to implementation

Through real-world examples and data-driven insights, panelists will illustrate the outcomes of an effective business case as well, sharing how AM can shorten time to market, enhance testing capabilities and patient feedback, and improve design flexibility, ultimately driving better patient outcomes.